Financial Summary (All financials)
| In millions, except per share items | Jun-30-22 | Dec-31-20 |
| Revenues | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 |
| Research and development | 1.1 | |
| General and administrative | 2.2 | 0.0 |
| EBIT | -3.5 | 0.0 |
| Pre-tax income | -3.5 | 0.0 |
| Income taxes | 0.0 | 0.0 |
| Tax rate | 0.0% | |
| Net income | -3.5 | 0.0 |
| |
| Diluted EPS | ($0.32) | ($0.02) |
| Shares outstanding (diluted) | 10.7 | 0.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|